OZVONTI

Serial Number 97060091
606

Registration Progress

Application Filed
Oct 5, 2021
Under Examination
Oct 11, 2022
Approved for Publication
Aug 16, 2022
Published for Opposition
Aug 16, 2022
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Jan 17, 2026 6 days
Revival assistance for abandoned trademark

Trademark Image

OZVONTI

Basic Information

Serial Number
97060091
Filing Date
October 5, 2021
Published for Opposition
August 16, 2022
Abandonment Date
November 17, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 17, 2025
Classes
005

Rights Holder

Spectrum Pharmaceuticals, Inc.

03
Address
157 Technology Drive
Irvine, CA 92618

Ownership History

Spectrum Pharmaceuticals, Inc.

Original Applicant
03
Irvine, CA

Spectrum Pharmaceuticals, Inc.

Owner at Publication
03
Irvine, CA

Legal Representation

Attorney
Tim Burgdorf

USPTO Deadlines

Next Deadline
6 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
January 17, 2026

Application History

40 events
Date Code Type Description Documents
Nov 17, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 17, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 16, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 16, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 11, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 11, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 5, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 4, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 11, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 4, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 12, 2024 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Nov 12, 2024 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Nov 12, 2024 PETG O PETITION TO REVIVE-GRANTED Loading...
Nov 12, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Nov 11, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 11, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 11, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 10, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 10, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 10, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 17, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 17, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 17, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 7, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 5, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 5, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 5, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 9, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Apr 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 10, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 10, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 11, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 16, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 16, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 27, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 8, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 8, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 29, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 8, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for the treatment of cancer; pharmaceuticals for oncological treatment

Classification

International Classes
005